Answers are grounded in this paper and cite their sources.
Identifying malignant cells in single-cell gene expression data is essential for understanding tumor heterogeneity, but existing computational methods can be slow and perform inconsistently across datasets. Here, we present InferPloidy, a framework that combines graph-based cell grouping with iterative probabilistic modeling to distinguish cells with normal and altered chromosome copy numbers using profiles generated by InferCNV. Across breast, lung, pancreatic, and colorectal cancer datasets, the evaluated workflow reduces computation time by up to two orders of magnitude compared with existing tools and improves agreement with published cell annotations. This classification supports the identification of established therapeutic targets and candidate cell surface markers associated with tumor subtypes. The low proportion of unclassified cells helps preserve information for downstream analyses of gene expression differences and tumor population characteristics. These findings support InferPloidy as an efficient framework for tumor cell stratification and biomarker discovery within the evaluated workflow. Its performance with inputs from other copy number inference methods requires further validation.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: